These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20212201)
21. A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema. Wiley HE; Thompson DJ; Bailey C; Chew EY; Cukras CA; Jaffe GJ; Lee RW; Loken EK; Meyerle CB; Wong W; Ferris FL Ophthalmology; 2016 Apr; 123(4):841-9. PubMed ID: 26875003 [TBL] [Abstract][Full Text] [Related]
22. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE. Pieramici DJ; Wang PW; Ding B; Gune S Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841 [TBL] [Abstract][Full Text] [Related]
23. Correlation between central subfield thickness, visual acuity and structural changes in diabetic macular edema. Hannouche RZ; Avila MP; Isaac DL; Silva RS; Rassi AR Arq Bras Oftalmol; 2012; 75(3):183-7. PubMed ID: 22872201 [TBL] [Abstract][Full Text] [Related]
24. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. Bressler NM; Beaulieu WT; Glassman AR; Blinder KJ; Bressler SB; Jampol LM; Melia M; Wells JA; JAMA Ophthalmol; 2018 Mar; 136(3):257-269. PubMed ID: 29392288 [TBL] [Abstract][Full Text] [Related]
26. Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life. Man RE; Fenwick EK; Sabanayagam C; Li LJ; Tey CS; Soon HJ; Cheung GC; Tan GS; Wong TY; Lamoureux EL Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4655-60. PubMed ID: 27603726 [TBL] [Abstract][Full Text] [Related]
27. Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. Bressler NM; Varma R; Doan QV; Gleeson M; Danese M; Bower JK; Selvin E; Dolan C; Fine J; Colman S; Turpcu A JAMA Ophthalmol; 2014 Feb; 132(2):168-73. PubMed ID: 24357541 [TBL] [Abstract][Full Text] [Related]
28. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF]. Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789 [TBL] [Abstract][Full Text] [Related]
29. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Chew EY; Davis MD; Danis RP; Lovato JF; Perdue LH; Greven C; Genuth S; Goff DC; Leiter LA; Ismail-Beigi F; Ambrosius WT; Ophthalmology; 2014 Dec; 121(12):2443-51. PubMed ID: 25172198 [TBL] [Abstract][Full Text] [Related]
30. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy. Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755 [TBL] [Abstract][Full Text] [Related]
31. Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME). Guyon B; Elphege E; Flores M; Gauthier AS; Delbosc B; Saleh M Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6241-6247. PubMed ID: 29228252 [TBL] [Abstract][Full Text] [Related]
32. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089 [TBL] [Abstract][Full Text] [Related]
33. Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies. Staurenghi G; Feltgen N; Arnold JJ; Katz TA; Metzig C; Lu C; Holz FG; Br J Ophthalmol; 2018 Jul; 102(7):954-958. PubMed ID: 29051325 [TBL] [Abstract][Full Text] [Related]
34. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. Bressler NM; Varma R; Suñer IJ; Dolan CM; Ward J; Ehrlich JS; Colman S; Turpcu A; Ophthalmology; 2014 Dec; 121(12):2461-72. PubMed ID: 25148789 [TBL] [Abstract][Full Text] [Related]
37. Impact of estimated glomerular filtration rate on diabetic macular edema. Temkar S; Karuppaiah N; Takkar B; Bhowmik D; Tripathi M; Ramakrishnan S; Sharma YR; Vohra R; Chawla R; Venkatesh P Int Ophthalmol; 2018 Jun; 38(3):1043-1050. PubMed ID: 28523527 [TBL] [Abstract][Full Text] [Related]
38. Diabetic macular edema: fundus autofluorescence and functional correlations. Vujosevic S; Casciano M; Pilotto E; Boccassini B; Varano M; Midena E Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):442-8. PubMed ID: 20720226 [TBL] [Abstract][Full Text] [Related]
39. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study. Bonnin S; Sandali O; Bonnel S; Monin C; El Sanharawi M Retina; 2015 May; 35(5):921-8. PubMed ID: 25545486 [TBL] [Abstract][Full Text] [Related]
40. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China. Wang N; Xu X; Zou H; Zhu J; Wang W; Ho PC Ophthalmologica; 2008; 222(1):32-6. PubMed ID: 18097178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]